Analysis of Requirements for the Medication Profile to Be Used in Clinical Research: Protocol Feasibility Studies and Patient Recruitment

Table 3

Results summary: identifying dosage instructions information in eligibility criteria.

Dose quantity	19 (9.5%)
Route of administration or “proxy”	27 (13.4%)
Indication for use	62 (30.8%)
Timing information	94 (46.8%)